Libido Drive Capsules – 102mg
PT-141 .5mg
Oxytocin 1mg
VIP .25mg
N-Acetyl L Tyrosine 100mg
Kisspeptin .25mg
Libido Drive is a research blend featuring PT-141, Oxytocin, N-Acetyl L-Tyrosine, Kisspeptin, and VIP, formulated to explore pathways related to mood, arousal, and hormonal balance. Each component contributes uniquely — PT-141 and Oxytocin are studied for their potential roles in promoting desire and connection, N-Acetyl L-Tyrosine supports neurotransmitter activity, while Kisspeptin and VIP are being researched for their influence on reproductive and vascular functions.
$250.00 / month
Libido Drive is a research compound blend combining PT-141, Oxytocin, VIP, N-Acetyl L-Tyrosine, and Kisspeptin, studied in laboratory research for their interaction with mood-related, arousal-related, and hormonal-signaling pathways. Advanced Peptide Institute supplies Libido Drive Capsules for laboratory research use only, at 99% purity and third-party tested for every batch.
What is Libido Drive?
Libido Drive is a five-compound research formulation combining PT-141 (bremelanotide), a synthetic melanocortin-receptor peptide; Oxytocin, a naturally occurring neurohypophysial peptide hormone; VIP (vasoactive intestinal peptide), a neuropeptide studied for its interaction with VPAC-receptor signaling; N-Acetyl L-Tyrosine, an amino-acid derivative studied in catecholamine-precursor research; and Kisspeptin, a peptide studied for its interaction with the KISS1 receptor and hypothalamic-pituitary-gonadal axis signaling. Each compound is studied in laboratory literature for its interaction with distinct receptor systems relevant to mood-signaling, arousal-related neural pathways, and hormonal-axis research. Advanced Peptide Institute’s Libido Drive Capsules combine these five research compounds into a single standardized format for researchers examining cross-pathway interactions, supplied strictly for laboratory research use at 99% purity with independent verification.
Research Applications
Libido Drive’s component compounds are studied across multiple receptor-signaling research contexts. PT-141 is examined in in vitro melanocortin-receptor (MC3R/MC4R) binding assays. Oxytocin is studied in neuroendocrine research models examining oxytocin-receptor signaling and its relationship to social- and mood-related neural pathways. VIP is researched for its interaction with VPAC1/VPAC2 receptors in cell-signaling assays. N-Acetyl L-Tyrosine is studied as a precursor compound in catecholamine-synthesis research. Kisspeptin is examined in hypothalamic-pituitary-gonadal axis research, including in vitro models of KISS1-receptor activation and downstream gonadotropin-releasing hormone signaling. Together, these compounds support researchers designing multi-receptor studies spanning melanocortin, oxytocin, VPAC, and kisspeptin-receptor pathways in controlled laboratory settings.
Purity & Third-Party Testing
Every batch of Advanced Peptide Institute Libido Drive Capsules is manufactured to 99% purity and independently verified using HPLC (high-performance liquid chromatography) and mass spectrometry. These orthogonal testing methods confirm both compound identity and purity level prior to release. A batch-specific Certificate of Analysis is available for every lot at https://advancedpeptideinstitute.com/certificate-of-analysis/.
Storage & Handling
Store Libido Drive Capsules in a cool, dry place away from direct sunlight and moisture, in their original sealed packaging. Keep out of reach of children. This product is intended strictly for laboratory research use.
Frequently Asked Questions
What purity is Advanced Peptide Institute Libido Drive Capsules?
Advanced Peptide Institute Libido Drive Capsules is supplied at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. A Certificate of Analysis is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/.
How should Libido Drive Capsules be stored?
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
What is Libido Drive studied for in laboratory research?
Libido Drive is studied in laboratory research for the interaction of its component peptides with mood-related, arousal-related, and hormonal-signaling pathways.
Published laboratory research on PT-141, oxytocin, and kisspeptin is indexed on PubMed.
Related Research Compounds: Limitless Capsules • BPC-157 Capsules – 500mcg • Browse all Capsules research compounds • Certificate of Analysis
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.